MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies_Oral, Esophagus, Pharynx, and Larynx
CDx Diagnostics
Organization & Developments: CDx
Parents
CDx Diagnostics
Children
2018: CDx Diagnostics Continues to Shine with Strong Data
CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx.
Clinicians use CDx brush biopsy instruments to non-invasively collect the tissue specimen of a suspect lesion.
EndoCDx brush biopsy, an office-based sampling of laryngeal tissue
EndoCDx EGD, a solution for the detection of Barrett's esophagus and esophageal dysplasia
EndoCDx LP, a in-office procedure for otolaryngologists that is used to identify dysplasia and early stage cancer of the larynx, pharynx, and surrounding tissues
EndoCDx transnasal esophagoscopy (TNE), a procedure that helps increase the reliability of TNE in evaluating esophageal disease
Its testing instruments are available to gastroenterologists, otolaryngologists, oral surgeons, periodontists, and dentists in the United States.
The company offers OralCDx, an accurate and non-invasive biopsy to evaluate common oral lesions to rule out dysplasia or cancer
Jumps
*Key People: CDx
Finance & Acquisitions: CDx